Results 11 to 20 of about 942,716 (313)

Whole organism high-content screening by label-free, image-based Bayesian classification for parasitic diseases. [PDF]

open access: yes, 2012
Sole reliance on one drug, Praziquantel, for treatment and control of schistosomiasis raises concerns about development of widespread resistance, prompting renewed interest in the discovery of new anthelmintics.
Bickle, Quentin D   +46 more
core   +2 more sources

Comparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screening. [PDF]

open access: yes, 2010
BACKGROUND: In view of the current widespread use of and reliance on a single schistosomicide, praziquantel, there is a pressing need to discover and develop alternative drugs for schistosomiasis.
Bickle, Quentin D   +7 more
core   +1 more source

Drug-drug interactions in the hospital [PDF]

open access: yes, 2007
Introduction Drug interaction screening programs are an important tool to check prescriptions of multiple drugs for potential drug-drug interactions (pDDIs). Several programs are available on the market.
Vonbach, Priska
core   +1 more source

Integrated dataset of screening hits against multiple neglected disease pathogens. [PDF]

open access: yes, 2011
New chemical entities are desperately needed that overcome the limitations of existing drugs for neglected diseases. Screening a diverse library of 10,000 drug-like compounds against 7 neglected disease pathogens resulted in an integrated dataset of 744 ...
Clive Yeates   +78 more
core   +1 more source

Microfluidic trends in drug screening and drug delivery

open access: yes, 2023
The low probability of a drug candidate's clinical success, the time consumed and the high cost of bringing a drug from concept to market emphasizes the need for new approaches to drug discovery. Recent innovations in microfluidic technologies, including
Feng, Jianguo   +4 more
core   +1 more source

Identification of imidazo[4,5-c]pyridin-2-one derivatives as novel Src family kinase inhibitors against glioblastoma

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2021
Glioblastoma multiforme (GBM) is the most common and malignant primary brain tumour in the central nervous system (CNS). As the ideal targets for GBM treatment, Src family kinases (SFKs) have attracted much attention.
Lishun Zhang   +11 more
doaj   +1 more source

Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays [PDF]

open access: yes, 2015
Schistosomiasis is responsible for a tremendous public health burden, yet only a single drug, praziquantel, is available. New antischistosomal treatments should therefore be developed. The accuracy, speed and objectivity of in vitro drug screening depend
Gordana Panic   +7 more
core   +1 more source

Hypoglycemic effect of Camellia chrysantha extract on type 2 diabetic mice model

open access: yesBangladesh Journal of Pharmacology, 2017
The aim of this study was to investigate the hypoglycemic effect of Camellia chrysantha using type 2 diabetic mice model. The ethyl acetate/dichloromethane extract exhibited the most effective hypoglycemic effect.
Lai Wang   +4 more
doaj   +1 more source

Is This Drug Screen Really Negative? Special Investigation of Drug Screening in Pediatrics [PDF]

open access: yesThe Journal of Applied Laboratory Medicine, 2017
We report a case of a child with a negative qualitative opioid result on a urine drug screen using our routine cutoff but a positive confirmation for heroin. A 3-month-old male presented to the emergency department after an unexplained episode of hypoxia.
Amy L, Pyle-Eilola   +3 more
openaire   +2 more sources

SRT1720 Alleviates ANIT-Induced Cholestasis in a Mouse Model

open access: yesFrontiers in Pharmacology, 2017
Intrahepatic cholestasis is a kind of clinical syndrome along with hepatotoxicity which caused by intrahepatic and systemic accumulations of bile acid. There are several crucial generating factors of the pathogenesis of cholestasis, such as inflammation,
Linxi Yu   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy